← Back to Clinical Trials
Recruiting NCT04813055

NCT04813055 Prospective Registry Of Therapeutic EndoscopiC ulTrasound

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04813055
Status Recruiting
Phase
Sponsor Paolo Giorgio Arcidiacono, MD
Condition Gastric Outlet Obstruction
Study Type OBSERVATIONAL
Enrollment 510 participants
Start Date 2020-12-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Therapeutic EUSPercutaneous ProceduresSurgical Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 510 participants in total. It began in 2020-12-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This registry aims to analyze long-term outcomes of therapeutic EUS (T-EUS) procedures, as well as to describe clinical and technical variables potentially predicting clinical success or adverse events, for a better selection of ideal candidates. The study also includes standard alternatives to T-EUS procedures for outcomes comparison.

Eligibility Criteria

Inclusion Criteria: * subjects candidate to therapeutic EUS (T-EUS) procedures for any underlying disease * subject eligible to T-EUS procedures but undergoing other non-EUS based endoscopic procedures, percutaneous or surgical procedures * 18 years old or older * able to provide an informed consent to inclusion. Exclusion Criteria: * age \< 18 years * inability or unwillingness to sign the informed consent form (ICF) * contra-indication for endoscopy or use of fluoroscopy

Contact & Investigator

Central Contact

Giuseppe Vanella, MD

✉ vanella.giuseppe@hsr.it

📞 +390226439574

Principal Investigator

Paolo Giorgio Arcidiacono, MD, FASGE

PRINCIPAL INVESTIGATOR

IRCCS San Raffaele Scientific Institute

Frequently Asked Questions

Who can join the NCT04813055 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Outlet Obstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04813055 currently recruiting?

Yes, NCT04813055 is actively recruiting participants. Contact the research team at vanella.giuseppe@hsr.it for enrollment information.

Where is the NCT04813055 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT04813055 clinical trial?

NCT04813055 is sponsored by Paolo Giorgio Arcidiacono, MD. The principal investigator is Paolo Giorgio Arcidiacono, MD, FASGE at IRCCS San Raffaele Scientific Institute. The trial plans to enroll 510 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology